Intravenious Treatment Holds Promise for Alcohol and Drug Addiction

Denver, CO, August 06, 2007 --(PR.com)-- New research into an obscure brain cell receptor found in the human brain has lead to a treatment that has been generating greater than 80% success for the past 12 months at a medical center in Denver, Colorado.

These brain cell receptors are a subclass of the super family of receptors called G-protein coupled receptors, which are made from amino acids.

"The specific receptor in question which is damaged in addiction is made up of 466 amino acids and found on the surface of only one in a million brain cells." Commented Tamea Sisco a certified addictionologist and scientific advisor to Excel, "this lead us to the so called 'Ah Ha!' moment."

If we were to administer the correct peptides and amino acids, in the correct proportion, to repair this receptor, would we be able to control addiction cravings?

"The answer seems to be an astounding, yes. We have now been administering this specific intravenous (IV) treatment for all types of addictive behavior with incredible success." Declared Dr. Wallace Arthur, Medical Director and scientific advisor of Excel.

"Amino acids are the building blocks of life, we just had to open our eyes and do our homework over again to determine which peptides and amino acids must be administered to relieve addiction.", Explained Dr. Arthur.

Tamea Sisco went on to add, "Safety isn't a problem, as each of the individual amino acids are FDA approved, the hard part was finding which amino acids were damaged in the G-receptor and how much to administer."

The treatment, termed "Tigers" treatment, is administered as a painless intravenous drip over 3-4 hours for a total of 10-20 treatments.

"Tigers" stands for TGGRS which is Third Generation Genetic Repair System and is now patent pending at the US Patent Office.

###